Kefei Wu
- Co-authors
- Benling QiLihua LiuJianwei TianLijuan BaiHaiping MaoJun FuYun LiuHongxia Liu
- Topics
- Acute Kidney Injury Research (5 papers)Dialysis and Renal Disease Management (3 papers)Chronic Kidney Disease and Diabetes (2 papers)
- Cited by
- NephrologyAgingCancer Research
- Partner nations
- ChinaPolandUnited States
In The Last Decade
Kefei Wu
26 papers receiving 469 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 176
- Immunology 75
- Nephrology 74
- Cancer Research 57
- Surgery 50
Countries citing papers authored by Kefei Wu
This map shows the geographic impact of Kefei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefei Wu more than expected).
Fields of papers citing papers by Kefei Wu
This network shows the impact of papers produced by Kefei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefei Wu. The network helps show where Kefei Wu may publish in the future.
Co-authorship network of co-authors of Kefei Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Kefei Wu. A scholar is included among the top collaborators of Kefei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefei Wu. Kefei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activationbreakdown → | 78 |
| 3 | 7 | |
| 4 | 31 | |
| 5 | 9 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 7 | |
| 9 | 21 | |
| 10 | 1 | |
| 11 | Evans Syndrome with Acute Kidney Injury. | 3 |
| 12 | 31 | |
| 13 | 19 | |
| 14 | 21 | |
| 15 | 9 | |
| 16 | 12 | |
| 17 | 16 | |
| 18 | 17 | |
| 19 | 26 | |
| 20 | 7 |
About Kefei Wu
Kefei Wu is a scholar working on Nephrology, Transplantation and Emergency Medicine, having authored 26 papers that have together received 471 indexed citations. Recurring topics across this work include Acute Kidney Injury Research (5 papers), Dialysis and Renal Disease Management (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Nephrology (74 citations), Aging (7 citations) and Cancer Research (57 citations). Kefei Wu has collaborated with scholars based in China, Poland and United States. Frequent co-authors include Benling Qi, Lihua Liu, Jianwei Tian, Lijuan Bai, Haiping Mao, Jun Fu, Yun Liu, Hongxia Liu, Hongyan Li and Wei Chen. Their work appears in journals such as PLoS ONE, Scientific Reports and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.